Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GLP-1s and Obesity Coverage: Differing Perspectives for Employers and Health Plans Posted on August 21, 2025 A Snippet From Our GLP-1 Spotlight Webinar Key Points Employers tend to view obesity as a chronic condition, while health plans lean slightly toward viewing obesity as a lifestyle condition
Patients interested in these programs can usually apply through the manufacturers official website or through their healthcare provider
Clinical Evidence Base and Regulatory Status BPC-157 has never been approved by the FDA for any human use
German startup Remi Health has raised $3.4 million to grow its mail order diagnostics offering, which helps users diagnose STIs through at-home blood and urine samples
While some healthcare providers continue to prescribe compounded peptides, the FDA peptide warning maintains that patients should be aware of the uncertainties surrounding these products and the potential risks associated with their use
synthesized Cys-NLC as potential nanocarriers for topical ocular administration of CsA [245]
US$ 25.35
US$ 20.38
US$ 25.72
US$ 29.41
